Product Information
LETROZOLE 2.5 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.1535 per EA under NDC 51991075990. Its NADAC has been published 174 times since Mar 1, 2023.
Strength
2.5 mg/1
Manufacturer
Breckenridge Pharmaceutical Inc.NDC
51991075990
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LETROZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA200161On Market Since
6/4/2011
Pharmacological Classes
Price Statistics
The NADAC for LETROZOLE 2.5 MG TABLET has been published 174 times since Mar 1, 2023, and over the history we have for it it has risen 50.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1535 per EA |
|---|---|
| All-time high | $0.1535 (Jun 24, 2026) |
| All-time low | $0.1009 (Jun 21, 2023) |
| 52-week high | $0.1535 |
| 52-week low | $0.1292 |
| Median price | $0.1383 |
| Average price | $0.1326 |
| Largest weekly change | +32.3% (Nov 22, 2023) |
| Weeks tracked | 174 |
| Tracking since | Mar 1, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LETROZOLE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LETROZOLE 2.5 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.1535 per EA (NDC 51991075990), effective Jun 24, 2026.
How has the price of LETROZOLE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LETROZOLE 2.5 MG TABLET has risen 50.0%. It has been tracked across 174 weekly CMS publications since Mar 1, 2023.
What are the highest and lowest recorded NADAC prices for LETROZOLE 2.5 MG TABLET?
Since Mar 1, 2023, the NADAC for LETROZOLE 2.5 MG TABLET has ranged from a low of $0.1009 (Jun 21, 2023) to a high of $0.1535 (Jun 24, 2026), with a median of $0.1383 per EA.
Are there cheaper alternatives to LETROZOLE 2.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as LETROZOLE 2.5 MG TABLET, but none are currently priced below it.
Who manufactures LETROZOLE 2.5 MG TABLET?
LETROZOLE 2.5 MG TABLET (NDC 51991075990) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification